FDA OKs First Oral Blood Thinning Medication for Children
Pradaxa approved for children ages 3 months to 12 years with VTE directly after treatment with injectable blood thinner for at least five days
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.